4//SEC Filing
Donegan Michael C 4
Accession 0001209191-23-012271
CIK 0000025743other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:11 PM ET
Size
5.6 KB
Accession
0001209191-23-012271
Insider Transaction Report
Form 4
Donegan Michael C
Vice President Finance
Transactions
- Award
Restricted Stock Units
2023-02-21+50,000→ 50,000 totalExercise: $0.00→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in full on March 31, 2023.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001627810
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:11 PM ET
- Size
- 5.6 KB